|
A double-blind, placebo-controlled multi-centre study to evaluate the efficacy and tolerability of Paroxetine in the treatment of post-stroke depression. |
paroxetine |
29060/625 |
|
Depressive Disorder, Major |
Phase 3 |
|
|
|
|
An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
May 2014 |